title: Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction.
authors.affiliation: Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Soejima
authors.forename: H
authors.initials: H
authors.lastname: Ogawa
authors.forename: H
authors.initials: H
authors.lastname: Suefuji
authors.forename: K
authors.initials: K
authors.lastname: Kaikita
authors.forename: K
authors.initials: K
authors.lastname: Takazoe
authors.forename: S
authors.initials: S
authors.lastname: Miyamoto
authors.forename: I
authors.initials: I
authors.lastname: Kajiwara
authors.forename: H
authors.initials: H
authors.lastname: Shimomura
authors.forename: T
authors.initials: T
authors.lastname: Sakamoto
authors.forename: M
authors.initials: M
authors.lastname: Yoshimura
authors.forename: S
authors.initials: S
authors.lastname: Nakamura
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D001779:Blood Coagulation Factors / Q000378:metabolism*; D004311:Double-Blind Method; D004656:Enalapril / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D019808:Losartan / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D015849:Plasminogen Inactivators / Q000097:blood; D015912:Thrombolytic Therapy; D013925:Thromboplastin / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000097:blood
chemical_list: D001779:Blood Coagulation Factors; D015849:Plasminogen Inactivators; D004656:Enalapril; D013925:Thromboplastin; D010959:Tissue Plasminogen Activator; D019808:Losartan